COUGH is the #2 most commonly reported adverse reaction for PECTIN, manufactured by Mondelez Global LLC. There are 11 FDA adverse event reports linking PECTIN to COUGH. This represents approximately 3.1% of all 356 adverse event reports for this drug.
Patients taking PECTIN who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH11 of 356 reports
COUGH is moderately reported among PECTIN users, representing a notable but not dominant share of adverse events.
Other Side Effects of PECTIN
In addition to cough, the following adverse reactions have been reported for PECTIN:
COUGH has been reported as an adverse event in 11 FDA reports for PECTIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with PECTIN?
COUGH accounts for approximately 3.1% of all adverse event reports for PECTIN, making it one of the most commonly reported side effect.
What should I do if I experience COUGH while taking PECTIN?
If you experience cough while taking PECTIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.